Add to ORKGdysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stent
loss and indirect costs associated with cardiovascular events and related clinical procedure
© The Author(s) 2015. This article is published with open access at Springerlink.com Revealing the i...
Objective: To assess the characteristics and short-term outcome of patients, undergoing percutaneous...
Stratification of coronary artery disease patients for revascularization procedure based o
Therapeutic effect of interventional therapy for unprotected left main coronary artery lesions in ag...
High-dose atorvastatin pretreatment could diminishes microvascular impair-ment in patients undergoin...
At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a st...
The article of record as published may be found at http://dx.doi.org/10.1111/1475-6773.12335National...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. ...
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcome
collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysi
The glycoprotein IIb/IIIa inhibitors (GPIs) represent a relatively new therapy for acute coronary sy...
Risk factors for impaired health status differ in women and men treated with percutaneous coronary i...
Cardiologists have been discussing emerging evidence that drug eluting stents (DES), as effective to...
loss and indirect costs associated with cardiovascular events and related clinical procedure
© The Author(s) 2015. This article is published with open access at Springerlink.com Revealing the i...
Objective: To assess the characteristics and short-term outcome of patients, undergoing percutaneous...
Stratification of coronary artery disease patients for revascularization procedure based o
Therapeutic effect of interventional therapy for unprotected left main coronary artery lesions in ag...
High-dose atorvastatin pretreatment could diminishes microvascular impair-ment in patients undergoin...
At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a st...
The article of record as published may be found at http://dx.doi.org/10.1111/1475-6773.12335National...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. ...
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcome
collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysi
The glycoprotein IIb/IIIa inhibitors (GPIs) represent a relatively new therapy for acute coronary sy...
Risk factors for impaired health status differ in women and men treated with percutaneous coronary i...
Cardiologists have been discussing emerging evidence that drug eluting stents (DES), as effective to...
loss and indirect costs associated with cardiovascular events and related clinical procedure
© The Author(s) 2015. This article is published with open access at Springerlink.com Revealing the i...
Objective: To assess the characteristics and short-term outcome of patients, undergoing percutaneous...